These Three Toilet Detection Health Technology Will Be In The United States, Iisrael, Japan Clinical Trials

Köögi- ja vannitoateave. Peavoolumeedia teave köögi ja vannitoa kohta

Israeli digital health startup OutSense was awarded a number of key innovation patents for IoT technology, foreign media reported on June 23. The technology gains life-saving medical insights by analyzing human excrement. Ettevõte on esitanud rea kolmest patendist, mis hõlmavad oma meditsiinilise tualettruumi anduri elemente.

The first OutSense patent is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet bowl to determine the optical signature of hidden blood in feces. Patents for this technology have been granted in the United States, Euroopa, Jaapan ja Hiina. A second patent has been granted in Europe and applications are pending for this patent in other countries. It allows effective analysis of the spatial distribution of the many components of stool and traces of blood. Based on this analysis, Ülevaadete tehnoloogia saab tuvastada vere allika seedetrakti teel. A third patent is pending for the technology, which detects urine dehydration components by analyzing urine and feces.

Vastavalt väljaannete tegevjuhi YFAT Scialomile, he predicts that “digitaalse meditsiini plahvatusega. This kind of monitoring will become the norm.” OutSense says the technology, which has already been approved and is pending approval, will provide broad protection for a person’s health by non-invasively extracting hidden blood from feces and urine. Hidden blood is critical for detecting colorectal cancer, põletikuline soolehaigus ja kuseteede infektsioonid. Its solution includes a multispectral optical sensor, valgusallikas ja autonoomne sõelumisseade, mis sisaldab WiFi -ühendust. The device scans human feces and identifies the optical footprint of fecal and urine components. It sends the data to an artificial intelligence-based cloud analysis, which then provides signs of various diseases with great precision.

OutSense develops tools to diagnose abnormalities in human feces. Proovitud verest saadud teave, koos verejooksu aja täiendava analüüsiga kuni eritumiseni, Esitab verejooksu patoloogia üksikasjad. Its specific patterns can determine whether the bleeding is from a fissure or hemorrhoid, or from a polyp, tumor or from an ulcer. In early June, Ülevaade teatas, et Communicare, suur tervishoiuettevõte, kus on rohkem kui 90 medical facilities in the United States, alustab sel aastal oma tehnoloogia piloteerimist. Lisaks sellele piloodile, OutSense plans to conduct clinical trials in Israel and Japan.